Sort
50,496 grants matching “lung cancer”
Nutrition, Metabolism, and Cancer
$940,099Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Small Molecule MYC Degraders as Novel Cancer Therapeutic Agents
$939,827Dennis Liang Fei · Stemsynergy Therapeutics, Inc. · R44 · FY2023 · CA
Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zrrovalpituzumab, a DLL3-targeting monoclonal antibody
$939,811John Thomas Poirier · New York University School Of Medicine · R01 · FY2021 · CA
CCR FACS Core Laboratory
$939,713Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Inpatient Technology-Supported Assisted Referral
$939,448Jeffrey L Fellows · Kaiser Foundation Research Institute · U01 · FY2011 · HL
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$939,361Xihong Lin · Harvard School Of Public Health · R35 · FY2022 · CA
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
$938,802Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2021 · CA
Illinois Oncology Research Association CCOP
$938,655John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2008 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$938,510University Of Colorado Denver · N01 · FY2010 · CA
CCR Genomics Core
$937,890Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
The connection of innate and adaptive anti-cancer immunity
$937,885John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$937,837Laura D Attardi · Stanford University · R35 · FY2023 · CA
Determining the Fate of Transmembrane Proteins
$937,490Allan M Weissman · Basic Sciences · Z01 · FY2007 · CA
Enabling Next Generation Machine Learning for Large Scale Image Analysis
$937,441Gerald Sabin · Rnet Technologies, Inc. · R44 · FY2023 · EB
Impact of Hearing Loss and Tinnitus in Cancer Survivors
$937,214Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2019 · CA
Preclinical development of TIMP-2 as a biologic therapy for cancer
$936,906William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
BLOOD-BASED BIOMARKERS FOR LUNG CANCER EARLY DETECTION AND EVALUATION OF CT-BASED LESIONS
$936,793British Columbia Cancer Agency Branch · · FY2010 · Department of the Army
Clinical production of viral vectors for cancer gene therapy
$936,788Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Ann Arbor regional CCOP
$936,494Saint Joseph Mercy Health System · U10 · FY2002 · CA
Mouse Models for Human Cancer
$936,359Raju S Kucherlapati · Brigham And Women'S Hospital · U01 · FY2007 · CA
Integrated, Individualized, Intelligent Prescribing (I3P)
$936,331Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2017 · HG
Targeting the Epigenome for Lung Cancer Therapy
$936,250David Schrump · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
BIOMARKERS OF LUNG CANCER SUSCEPTIBILITY IN MINORITIES
$936,192University Of California San Francisco · R01 · FY2000 · ES
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
$936,142Nathanael Schiander Gray · Stanford University · OT2 · FY2024 · CA
Dayton Clinical Oncology Program
$936,120Howard M Gross · Dayton Clinical Oncology Program · UG1 · FY2017 · CA